You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Medtronic
McKesson
Mallinckrodt
Johnson and Johnson

Last Updated: April 18, 2021

DrugPatentWatch Database Preview

ILOPERIDONE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Iloperidone patents expire, and when can generic versions of Iloperidone launch?

Iloperidone is a drug marketed by Inventia and Taro Pharm Inds Ltd and is included in two NDAs.

The generic ingredient in ILOPERIDONE is iloperidone. There are eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the iloperidone profile page.

Drug patent expirations by year for ILOPERIDONE
Recent Clinical Trials for ILOPERIDONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Patient-Centered Outcomes Research InstitutePhase 4
Melissa DelbelloPhase 4
Janssen Scientific Affairs, LLCPhase 4

See all ILOPERIDONE clinical trials

Pharmacology for ILOPERIDONE
Paragraph IV (Patent) Challenges for ILOPERIDONE
Tradename Dosage Ingredient NDA Submissiondate
FANAPT TABLET;ORAL iloperidone 022192 2013-05-06

US Patents and Regulatory Information for ILOPERIDONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Inventia ILOPERIDONE iloperidone TABLET;ORAL 207231-001 Nov 28, 2016 DISCN No No   Start Trial   Start Trial   Start Trial
Inventia ILOPERIDONE iloperidone TABLET;ORAL 207231-007 Nov 28, 2016 DISCN No No   Start Trial   Start Trial   Start Trial
Inventia ILOPERIDONE iloperidone TABLET;ORAL 207231-004 Nov 28, 2016 DISCN No No   Start Trial   Start Trial   Start Trial
Taro Pharm Inds Ltd ILOPERIDONE iloperidone TABLET;ORAL 207098-005 Jul 22, 2019 DISCN No No   Start Trial   Start Trial   Start Trial
Taro Pharm Inds Ltd ILOPERIDONE iloperidone TABLET;ORAL 207098-001 Jul 22, 2019 DISCN No No   Start Trial   Start Trial   Start Trial
Taro Pharm Inds Ltd ILOPERIDONE iloperidone TABLET;ORAL 207098-007 Jul 22, 2019 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
McKinsey
Johnson and Johnson
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.